LOX and gastric cancer: LOX-lysyl oxidase, the enzyme highly overexpressed in tumors derived from CAFs, acts as a collagen crosslinking initiator in several cancers like breast and gastric cancers, ultimately enhancing EMT, cell survival, invasion, drug resistance, and angiogenesis [16].